Novo Nordisk to provide more information on psychiatric side effects
So far, there is no proven link between Novo Nordisk’s diabetes drug Ozempic and weight loss drug Wegovy and increased thoughts of suicide and self-harm, but the case is not closed.
by marketwire
The European drug regulatory authorities have initially not found a causal link between medicines such as Novo Nordisk’s weight loss medicine Wegovy and serious psychiatric side effects, but now the authorities are asking Novo Nordisk and the other pharmaceutical companies that manufacture the medicine for further information, writes Berlingske.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
